Sign up
Pharma Capital

Neurotrope anticipates data from its drug to treat Alzheimer's summer 2019

Neurotrope Inc (NASDAQ:NTRP) CEO Dr. Charles Ryan sat down with Proactive Investors at the BIO CEO & Investor Conference in New York.

Ryan says the company anticipates data from its drug to treat Alzheimer's summer 2019.

 

View full NTRP profile View Profile
View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.